MassIVE MSV000096852

Partial Public

GNPS - Improved MALDI-MS Imaging of Polar and 2H-Labeled Metabolites in Mouse Organ Tissues

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) is an indispensable analytical tool to depict the spatial distribution of analytes such as polar metabolites, lipids, proteins, and drugs in biological specimens. Imaging small polar metabolites and analyzing their in-vivo dynamics with stable isotope labeled (SIL) tracing through various biochemical pathways, including citric acid (TCA) cycle, glycolysis, and amino acid metabolism, has gained substantial interest over the years. However, imaging these polar metabolites across different tissue types is limited due to their lower ionization efficiencies and ion suppression from other abundant biomolecules. These challenges can be further exacerbated with SIL studies, which require the improvement of sample preparation methods. Solvent pretreatments before matrix application on a tissue section have the potential to improve the sensitivity, but often challenges with validation of spatial distribution of metabolites revealed in MALDI-MSI. Here, we present a optimized 'basic hexane' wash method that improved the detection of small molecules with exceptional sensitivity up to several folds for polar and 2H labeled glycolytic metabolites across five different mouse organ tissues (kidney, heart, brain, liver, and brown adipose tissue). Further, we addressed one of the major concerns such as validation of localised polar metabolites within the tissue regions by implementing spatial validation workflow. The workflow depicts the use of region of interest guided laser capture microdissection of tissue regions followed by LC-MS/MS. Indeed, majority of metabolites showed an excellent corroboration with distribution of metabolites in MALDI-MSI and LMD-LC-MS/MS. Besides, we also observed the similar effect on boosting signal intensities of polar metabolites extracted from the microsampled tissues using LMD followed by LC-MS/MS. Overall, we provided an improved MALDI sample pretreatment approach and the spatial validation workflow to understand polar metabolite distribution in mouse organs. [doi:10.25345/C5WS8HZ5Q] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: MALDI-MSI ; Metabolomics ; Laser capture microdissection ; LC-MS/MS ; Spatial validation ; DatasetType:Metabolomics

Contact

Principal Investigators:
(in alphabetical order) 		Dr. Prasad Phapale, Leibniz-Institut fuer Analytische Wissenschaften-ISAS-e.V., Germany
Submitting User: Kasarla04
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

GNPS content goes here (MSV000096852 [task=cc12305719e6400c8a7e36ef97fccbbc])
Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.